Vitolo, Marco
 Distribuzione geografica
Salva come PNG Salva come JPEG
Continente #
NA - Nord America 3.083
EU - Europa 1.538
AS - Asia 751
OC - Oceania 8
AF - Africa 3
SA - Sud America 3
Totale 5.386
Salva come PNG Salva come JPEG
Nazione #
US - Stati Uniti d'America 3.058
IT - Italia 644
SE - Svezia 337
HK - Hong Kong 266
CN - Cina 223
GB - Regno Unito 193
SG - Singapore 162
DE - Germania 96
FI - Finlandia 77
BG - Bulgaria 51
FR - Francia 51
ID - Indonesia 46
LT - Lituania 19
CA - Canada 18
IN - India 17
RU - Federazione Russa 14
IE - Irlanda 11
MY - Malesia 11
AU - Australia 7
CH - Svizzera 7
RS - Serbia 7
TR - Turchia 7
CZ - Repubblica Ceca 6
ES - Italia 6
JP - Giappone 6
CU - Cuba 5
PL - Polonia 5
UA - Ucraina 4
NL - Olanda 3
AT - Austria 2
BR - Brasile 2
GE - Georgia 2
IR - Iran 2
JO - Giordania 2
TH - Thailandia 2
AE - Emirati Arabi Uniti 1
BE - Belgio 1
BZ - Belize 1
CL - Cile 1
DZ - Algeria 1
EE - Estonia 1
EG - Egitto 1
GR - Grecia 1
KZ - Kazakistan 1
MA - Marocco 1
MK - Macedonia 1
MX - Messico 1
NZ - Nuova Zelanda 1
RO - Romania 1
SA - Arabia Saudita 1
TW - Taiwan 1
VN - Vietnam 1
Totale 5.386
Salva come PNG Salva come JPEG
Città #
Chandler 427
Fairfield 395
Ashburn 342
Nyköping 283
Hong Kong 266
Woodbridge 169
Houston 157
Seattle 150
New York 132
Wilmington 130
Cambridge 125
Singapore 118
San Diego 105
Beijing 86
Princeton 69
Ann Arbor 67
Southend 63
Helsinki 62
Bologna 57
Milan 55
Sofia 50
Modena 47
Rome 47
London 45
Jakarta 43
Shanghai 40
Kilburn 26
Parma 20
Jacksonville 15
Lappeenranta 15
Toronto 15
Eugene 14
Munich 13
Norwalk 11
Perugia 11
Turin 11
Dearborn 10
Dublin 10
Naples 9
Pisa 9
Redwood City 9
Reggio Emilia 9
Brescia 8
Des Moines 8
San Giuliano Milanese 8
Belgrade 7
Florence 7
Hounslow 7
Islington 7
Phoenix 7
Vigasio 7
Brno 6
Esslingen am Neckar 6
Guangzhou 6
Paris 6
Sassuolo 6
Arceto 5
Bremen 5
Castagneto Carducci 5
Castelfranco Emilia 5
Chiswick 5
Falls Church 5
Fremont 5
Havana 5
Prato 5
Prescot 5
Scicli 5
Ancona 4
Bari 4
Castelfranco Veneto 4
Chicago 4
Fidenza 4
Liverpool 4
Palermo 4
Pontassieve 4
Ravenna 4
San Mateo 4
Adelfia 3
Bern 3
Besana in Brianza 3
Boardman 3
Cagliari 3
Frankfurt Am Main 3
Izmir 3
Kolkata 3
Livorno 3
Los Angeles 3
Monsano 3
New Bedfont 3
Pavia 3
Pavullo Nel Frignano 3
Pescara 3
Pistoia 3
Sala Baganza 3
Saludecio 3
San Jose 3
Serra San Bruno 3
Shenzhen 3
Southwark 3
Suri 3
Totale 3.997
Salva come PNG Salva come JPEG
Nome #
Cardiolaminopathies from bench to bedside: challenges in clinical decision-making with focus on arrhythmia-related outcomes 174
Device-detected atrial high rate episodes and the risk of stroke/thrombo-embolism and atrial fibrillation incidence: a systematic review and meta-analysis 138
The role of physical activity in individuals with cardiovascular risk factors: an opinion paper from Italian Society of Cardiology-Emilia Romagna-Marche and SIC-Sport 127
Cardioversion of recent-onset atrial fibrillation: current evidence, practical considerations, and controversies in a complex clinical scenario 124
Clinical complexity and impact of the ABC (Atrial fibrillation Better Care) pathway in patients with atrial fibrillation: a report from the ESC-EHRA EURObservational Research Programme in AF General Long-Term Registry 118
What do we do about atrial high rate episodes? 107
The Euro Heart Survey and EURObservational Research Programme (EORP) in atrial fibrillation registries: contribution to epidemiology, clinical management and therapy of atrial fibrillation patients over the last 20 years 103
2022 ESC Guidelines for the management of ventricular arrhythmias and sudden cardiac death: an important focus on a multidisciplinary approach to a tailored diagnostic and therapeutic work-up|Linee guida europee 2022 su aritmie ventricolari e morte cardiaca improvvisa: un importante impulso a un impegno multidisciplinare in campo diagnostico e terapeutico per un’accurata personalizzazione dell’approccio clinico 99
Long-term outcomes of postoperative atrial fibrillation following non cardiac surgery: A systematic review and metanalysis 94
Female sex and stroke in atrial fibrillation: an intriguing relationship 93
Atrial fibrillation and remote monitoring through cardiac implantable electronic devices in heart failure patients 92
Radar-Based Monitoring of Vital Signs: A Tutorial Overview 91
Managing atrial fibrillation: the need for an individualized approach even in the emergency department 91
Cognitive impairment in patients with atrial fibrillation: Implications for outcome in a cohort study 90
Usefulness of Red Cells Distribution Width to Predict Worse Outcomes in Patients With Atrial Fibrillation 88
From meta-analysis to the individual patient with atrial fibrillation and coronary artery disease: the complexity of antithrombotic treatment in real-world clinical practice and the need for a tailored approach 87
Percutaneous pericardiocentesis for pericardial effusion: predictors of mortality and outcomes 83
Radiotherapy-induced malfunctions of cardiac implantable electronic devices in cancer patients 82
Atrial fibrillation in patients with cardiac implantable electronic devices: New perspectives with important clinical implications 80
Grey zones in the practice of permanent cardiac pacing: The case of preventive pacing for improving rhythm control in atrial fibrillation 80
COVID-19 pandemic: complex interactions with the arrhythmic profile and the clinical course of patients with cardiovascular disease 80
Anticoagulation to prevent ischemic stroke in patients with atrial fibrillation: a complex scenario including underdiagnosis, undertreatment or underdosing of oral anticoagulants 78
Cardiac resynchronization therapy: Need to synchronize patients and device longevities with comorbidities 77
Antithrombotic treatment in atrial fibrillation patients undergoing percutaneous coronary interventions: focus on stent thrombosis 77
Atrial fibrillation pattern and factors affecting the progression to permanent atrial fibrillation 76
Red cell distribution width: a routinely available biomarker with important clinical implications in patients with atrial fibrillation 76
Cardiomyopathy associated with long-term right ventricular pacing: an intriguing clinical issue 74
Permanent Atrial Fibrillation as the Terminal Stage of a Chronic Disease: Palliative Care Needs to be Considered in Selected Patients with Markedly Impaired Quality of Life 74
Tailored oral anticoagulant prescription in patients with atrial fibrillation: Use and misuse of clinical risk prediction scores 71
The importance of adherence and persistence with oral anticoagulation treatment in patients with atrial fibrillation 71
The 12-lead ECG: A continuous reference for the cardiologist 67
Cardiac resynchronization therapy: variations across Europe in implant rates and types of implanted devices 66
Atrial high-rate episodes: clinical significance, prognostic impact and clinical management 65
Biomarkers in atrial fibrillation: A constant search for simplicity, practicality, and cost-effectiveness 64
Optimizing indices of atrial fibrillation susceptibility and burden to evaluate atrial fibrillation severity, risk and outcomes 63
Red blood cell distribution width in patients undergoing transcatheter aortic valve implantation: Implications for outcomes 62
Driving restriction in patients with cardiac implantable electronic devices: an overview of worldwide regulations 60
Beyond the 2020 guidelines on atrial fibrillation of the European society of cardiology 60
Clinical Factors Associated with Atrial Fibrillation Detection on Single-Time Point Screening Using a Hand-Held Single-Lead ECG Device 58
Comparing outcomes in asymptomatic and symptomatic atrial fibrillation: A systematic review and meta-analysis of 81,462 patients 58
Impact of body mass index on the outcome of elderly patients treated with transcatheter aortic valve implantation 57
Real-world applicability and impact of early rhythm control for European patients with atrial fibrillation: a report from the ESC-EHRA EORP-AF Long-Term General Registry 56
Infective endocarditis in patients with cardiac implantable electronic devices: Impact of comorbidities on outcome 54
Burden of disease and costs of infections associated with cardiac implantable electronic devices 51
Atrial cardiomyopathy: a derangement in atrial volumes, geometry, function, and pathology with important clinical implications 51
The challenge to improve knowledge on the interplay between subclinical atrial fibrillation, atrial cardiomyopathy, and atrial remodeling 50
Comparison of HAS-BLED and ORBIT Bleeding Risk Scores in AF Patients treated with NOACs: A Report from the ESC-EHRA EORP-AF General Long-Term Registry 50
Impact of clinical phenotypes on management and outcomes in European atrial fibrillation patients: a report from the ESC-EHRA EURObservational Research Programme in AF (EORP-AF) General Long-Term Registry 49
Clinical Profile, Arrhythmias, and Adverse Cardiac Outcomes in Emery–Dreifuss Muscular Dystrophies: A Systematic Review of the Literature 48
Prevalence, management and impact of chronic obstructive pulmonary disease in atrial fibrillation: a systematic review and meta-analysis of 4,200,000 patients 47
Clinical phenotype classification of atrial fibrillation patients using cluster analysis and associations with trial-adjudicated outcomes 46
Atrial Fibrillation in the Setting of Acute Pneumonia: Not a Secondary Arrhythmia 46
DIGItal Health Literacy after COVID-19 Outbreak among Frail and Non-Frail Cardiology Patients: The DIGI-COVID Study 45
Red cell distribution width and patient outcome in cardiovascular disease: A ‘’real-world” analysis 45
Digital literacy as a potential barrier to implementation of cardiology tele-visits after COVID-19 pandemic: The INFO-COVID survey 45
The search for a gold standard to clinically diagnose and monitor atrial cardiomyopathy 42
Atrial fibrillation screening: Great debate on which approach to apply, which tools to use and which population to target 41
Infections associated with cardiac electronic implantable devices: economic perspectives and impact of the TYRX™ antibacterial envelope 41
Atrial high rate episodes as a marker of atrial cardiomyopathy: In the quest of the Holy Grail. Author's reply 41
Implantable cardioverter defibrillators and devices for cardiac resynchronization therapy: what perspective for patients’ apps combined with remote monitoring? 41
Rhythm- or rate-control strategies according to 4S-AF characterization scheme and long-term outcomes in atrial fibrillation patients: the FAMo (Fibrillazione Atriale in Modena) cohort 40
Clinical implications of assessing frailty in elderly patients treated with permanent cardiac pacing 39
Chronic Kidney Disease with Mild and Mild to Moderate Reduction in Renal Function and Long-Term Recurrences of Atrial Fibrillation after Pulmonary Vein Cryoballoon Ablation 38
Atrial Fibrillation and the Risk of Early‐Onset Dementia: A Systematic Review and Meta‐Analysis 36
Anthropometric parameters and radiation doses during percutaneous coronary procedures 36
How did COVID-19 affect medical and cardiology journals? A pandemic in literature 36
Impact of COVID-19 in emergency medicine literature: a bibliometric analysis 32
Ibrutinib and Bruton's tyrosine kinase inhibitors in chronic lymphocytic leukemia: focus on atrial fibrillation and ventricular tachyarrhythmias/sudden cardiac death 31
Cardiac troponins and adverse outcomes in European patients with atrial fibrillation: A report from the ESC-EHRA EORP atrial fibrillation general long-term registry 31
Kidney Function According to Different Equations in Patients Admitted to a Cardiology Unit and Impact on Outcome 31
Comparing atrial fibrillation guidelines: Focus on stroke prevention, bleeding risk assessment and oral anticoagulant recommendations 31
Impact of anthropometric factors on outcomes in atrial fibrillation patients: analysis on 10 220 patients from the European Society of Cardiology (ESC)-European Heart Rhythm Association (EHRA) EurObservational Research Programme on Atrial Fibrillation (EORP-AF) general long-term registry 30
Erratum: Publisher's note to: Optimizing indices of atrial fibrillation susceptibility and burden to evaluate atrial fibrillation severity, risk and outcomes (Cardiovascular Research (cvab147) DOI: 10.1093/cvr/cvab147) 30
Asymptomatic vs. symptomatic atrial fibrillation: Clinical outcomes in heart failure patients 29
Mobile health technology in atrial fibrillation 29
Performance-based risk-sharing arrangements for devices and procedures in cardiac electrophysiology: an innovative perspective 27
Short and long-term outcomes after cardiac surgery in Jehovah's Witnesses patients: a case-control study 26
Cardiac Surgery in Jehovah's Witnesses Patients and Association With Peri-Operative Outcomes: A Systematic Review and Meta-Analysis 26
Three-Dimensional Automated, Machine-Learning-Based Left Heart Chamber Metrics: Associations with Prevalent Vascular Risk Factors and Cardiovascular Diseases 25
Atrial fibrillation in pneumonia: what clinical implications at long-term? 25
Dronedarone for the treatment of atrial fibrillation with concomitant heart failure and preserved or mildly reduced ejection fraction: closer to Ithaca after a long odyssey? 25
Ventricular and Atrial Remodeling after Transcatheter Edge-to-Edge Repair: A Pilot Study 24
A systematic review and meta-analysis on oncological radiotherapy in patients with a cardiac implantable electronic device: Prevalence and predictors of device malfunction in 3121 patients 24
Single-lead VDD pacing: a literature review on short-term and long-term performance 23
Implantable cardioverter-defibrillators for primary prevention of sudden cardiac death: what are the barriers to implementation in the ‘real world’? 21
Low Occurrence of Infections and Death in a Real-World Cohort of Patients with Cardiac Implantable Electronic Devices 20
Epidemiology and impact of frailty in patients with atrial fibrillation in Europe 20
Features of Clinical Complexity in European Patients With Atrial Fibrillation: A Report From a European Observational Prospective AF Registry 20
Impact of ABC (Atrial Fibrillation Better Care) pathway adherence in high-risk subgroups with atrial fibrillation: A report from the ESC-EHRA EORP-AF long-term general registry 20
Impact of malignancy on outcomes in European patients with atrial fibrillation: A report from the ESC-EHRA EURObservational research programme in atrial fibrillation general long-term registry 19
Atrial fibrillation post-coronary or cardiac surgery: A transient inflammation-related event or the expression of a pre-existing arrhythmogenic atrial substrate? 18
New Perspectives on Risk Stratification and Treatment in Patients with Atrial Fibrillation: An Analysis of Recent Contributions on the Journal of Cardiovascular Disease and Development 18
Letter by Imberti et al Regarding Article, "DREAM-ICD-II Study" 17
Understanding the global burden of atrial fibrillation and regional variations: We need improvement 16
Factors Associated with Progression of Atrial Fibrillation and Impact on All-Cause Mortality in a Cohort of European Patients 16
The Interplay of PR Interval and AV Pacing Delays Used for Cardiac Resynchronization Therapy in Heart Failure Patients: Association with Clinical Response in a Retrospective Analysis of a Large Observational Study 16
Effectiveness of atrial fibrillation ablation in heart failure across the entire spectrum of left ventricular ejection fraction 16
Atrial fibrillation and HIV: a new association requiring pathophysiological and outcome studies 16
Cooling dynamics: a new predictor of long-term efficacy of atrioventricular nodal reentrant tachycardia cryoablation 14
Comparative analysis of level of evidence and class of recommendation for 50 clinical practice guidelines released by the European Society of Cardiology from 2011 to 2022 14
Totale 5.369
Salva come PNG Salva come JPEG
Categoria #
all - tutte 51.167
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 51.167
Salva come PNG Salva come JPEG


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2019/2020205 0 1 11 11 8 21 20 21 60 26 24 2
2020/2021918 32 35 73 59 78 37 227 95 74 70 67 71
2021/20221.164 72 80 20 38 39 102 30 57 128 99 244 255
2022/20231.454 155 154 119 69 125 175 49 149 206 44 130 79
2023/20241.648 52 86 107 170 283 238 123 213 38 51 87 200
2024/2025138 131 7 0 0 0 0 0 0 0 0 0 0
Totale 5.550